Kelly Maresh

1.3k total citations
16 papers, 1.0k citations indexed

About

Kelly Maresh is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Kelly Maresh has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 5 papers in Internal Medicine. Recurrent topics in Kelly Maresh's work include Acute Myocardial Infarction Research (10 papers), Coronary Interventions and Diagnostics (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Kelly Maresh is often cited by papers focused on Acute Myocardial Infarction Research (10 papers), Coronary Interventions and Diagnostics (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Kelly Maresh collaborates with scholars based in United States, Italy and Canada. Kelly Maresh's co-authors include Neal S. Kleiman, Juan F. Granada, Eli I. Lev, Timothy DeLao, Sasidhar Guthikonda, Rajnikant Patel, Paul F. Bray, David J. Cohen, Deborah Nassif and John J. López and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Kelly Maresh

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Maresh United States 11 927 641 305 134 91 16 1.0k
Petr Widimský Czechia 17 1.2k 1.3× 560 0.9× 231 0.8× 220 1.6× 74 0.8× 36 1.3k
Alex Hobson United Kingdom 13 593 0.6× 377 0.6× 166 0.5× 212 1.6× 98 1.1× 26 758
Pierre Déguisé Canada 7 940 1.0× 512 0.8× 376 1.2× 274 2.0× 151 1.7× 10 1.2k
Martin M. Zenni United States 20 1.3k 1.4× 749 1.2× 369 1.2× 158 1.2× 77 0.8× 41 1.5k
Jayne Prats United States 18 1.1k 1.2× 735 1.1× 298 1.0× 65 0.5× 74 0.8× 65 1.3k
Steven B. Shoemaker United States 8 619 0.7× 374 0.6× 173 0.6× 144 1.1× 39 0.4× 12 754
Hildegard Bollwein Germany 10 1.2k 1.3× 761 1.2× 183 0.6× 372 2.8× 41 0.5× 12 1.3k
Salvatore Colangelo Italy 11 540 0.6× 385 0.6× 110 0.4× 92 0.7× 64 0.7× 21 631
Neil Sawhney United States 10 800 0.9× 639 1.0× 203 0.7× 187 1.4× 162 1.8× 12 981
Yücel Balbay Türkiye 17 388 0.4× 261 0.4× 80 0.3× 101 0.8× 90 1.0× 43 616

Countries citing papers authored by Kelly Maresh

Since Specialization
Citations

This map shows the geographic impact of Kelly Maresh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Maresh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Maresh more than expected).

Fields of papers citing papers by Kelly Maresh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Maresh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Maresh. The network helps show where Kelly Maresh may publish in the future.

Co-authorship network of co-authors of Kelly Maresh

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Maresh. A scholar is included among the top collaborators of Kelly Maresh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Maresh. Kelly Maresh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kodali, Sudha, Constance M. Mobley, Ashish Saharia, et al.. (2024). Effect of a Hispanic outreach program on referral and liver transplantation volume at a single center. Transplant Immunology. 84. 102034–102034. 3 indexed citations
2.
Maresh, Kelly, et al.. (2017). Clinical Research Nursing: Development of a Residency Program. Clinical journal of oncology nursing. 21(5). 633–636. 9 indexed citations
3.
Gidaro, Teresa, Laurent Servais, Stefano C. Previtali, et al.. (2017). Rimeporide: safety, tolerability and pharmacokinetic results from a phase Ib study in DMD boys as well as exploratory biomarkers. Neuromuscular Disorders. 27. S215–S216. 3 indexed citations
4.
Jeremias, Allen, Neal S. Kleiman, Deborah Nassif, et al.. (2008). Prevalence and Prognostic Significance of Preprocedural Cardiac Troponin Elevation Among Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Circulation. 118(6). 632–638. 50 indexed citations
5.
Win, Htut K., Angel Caldera, Kelly Maresh, et al.. (2007). Clinical Outcomes and Stent Thrombosis Following Off-Label Use of Drug-Eluting Stents. JAMA. 297(18). 2001–2001. 258 indexed citations
6.
Patel, Rajnikant, Eli I. Lev, Muthiah Vaduganathan, et al.. (2007). Platelet reactivity among Asian Indians and Caucasians. Platelets. 18(4). 261–265. 11 indexed citations
7.
Lev, Eli I., Carlos L. Alviar, Mehmet Erdinç Arıkan, et al.. (2006). Platelet reactivity in patients with subacute stent thrombosis compared with non–stent-related acute myocardial infarction. American Heart Journal. 153(1). 41.e1–41.e6. 23 indexed citations
8.
Lev, Eli I., Rajnikant Patel, Kelly Maresh, et al.. (2005). Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 47(1). 27–33. 358 indexed citations
9.
Cohen, David J., et al.. (2005). Design of a registry to characterize “real-world” outcomes of percutaneous coronary revascularization in the drug-eluting stent era. American Heart Journal. 150(5). 887–892. 28 indexed citations
10.
Kleiman, Neal S., H. A. Rubin, Stuart Solomon, et al.. (2002). Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide. American Heart Journal. 143(4). 585–593. 21 indexed citations
11.
Tcheng, James E., J.Conor O’Shea, Bonnie H. Weiner, et al.. (2002). Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Journal of the American College of Cardiology. 40(6). 1085–1091. 42 indexed citations
12.
13.
Kereiakes, Dean J., Neal S. Kleiman, Edward T.A. Fry, et al.. (2001). Dalteparin in combination with abciximab during percutaneous coronary intervention. American Heart Journal. 141(3). 348–352. 58 indexed citations
14.
Turner, Nancy A., Neal S. Kleiman, Kelly Maresh, et al.. (2000). Effects of Abciximab, Ticlopidine, and Combined Abciximab/Ticlopidine Therapy on Platelet and Leukocyte Function in Patients Undergoing Coronary Angioplasty. Circulation. 101(10). 1122–1129. 35 indexed citations
15.
Kleiman, Neal S., Robert E. Jordan, Ellen T. Lance, et al.. (2000). Ticlopidine Enhances the Platelet Inhibitory Capacity of Abciximab In Vitro. Journal of Thrombosis and Thrombolysis. 9(1). 29–36. 5 indexed citations
16.
Kleiman, Neal S., Kelly Maresh, Rebecca J. Taylor, et al.. (2000). Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: Ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions. American Heart Journal. 140(3). 492–501. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petr Widimský Breakdown of academic impact, for papers by Alex Hobson Breakdown of academic impact, for papers by Pierre Déguisé Breakdown of academic impact, for papers by Martin M. Zenni Breakdown of academic impact, for papers by Jayne Prats Breakdown of academic impact, for papers by Steven B. Shoemaker Breakdown of academic impact, for papers by Hildegard Bollwein Breakdown of academic impact, for papers by Salvatore Colangelo Breakdown of academic impact, for papers by Neil Sawhney Breakdown of academic impact, for papers by Yücel Balbay
Rankless by CCL
2026